Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Harmony Biosciences Holdings (HRMY) Non Operating Income (2020 - 2025)

Historic Non Operating Income for Harmony Biosciences Holdings (HRMY) over the last 6 years, with Q3 2025 value amounting to -$106000.0.

  • Harmony Biosciences Holdings' Non Operating Income rose 1451.61% to -$106000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$415000.0, marking a year-over-year decrease of 108571.43%. This contributed to the annual value of -$68000.0 for FY2024, which is 14276.73% down from last year.
  • According to the latest figures from Q3 2025, Harmony Biosciences Holdings' Non Operating Income is -$106000.0, which was up 1451.61% from -$193000.0 recorded in Q2 2025.
  • Harmony Biosciences Holdings' 5-year Non Operating Income high stood at $193000.0 for Q4 2023, and its period low was -$276000.0 during Q1 2025.
  • For the 5-year period, Harmony Biosciences Holdings' Non Operating Income averaged around -$16666.7, with its median value being $0.0 (2022).
  • In the last 5 years, Harmony Biosciences Holdings' Non Operating Income surged by 95000.0% in 2022 and then crashed by 715000.0% in 2024.
  • Harmony Biosciences Holdings' Non Operating Income (Quarter) stood at $31000.0 in 2021, then skyrocketed by 135.48% to $73000.0 in 2022, then skyrocketed by 164.38% to $193000.0 in 2023, then fell by 17.1% to $160000.0 in 2024, then crashed by 166.25% to -$106000.0 in 2025.
  • Its last three reported values are -$106000.0 in Q3 2025, -$193000.0 for Q2 2025, and -$276000.0 during Q1 2025.